Led and developed high-impact initiatives to drive HCP action, triggering earlier therapy escalation for rare disease patients and elevating the Standard of Care [SoC]. Practiced cross-functional leadership and consensus building to rally the organization around patient adherence strategies and competitive differentiation. Accelerated growth and maintained market leadership to position UPTRAVI for blockbuster status in 2021.• Developed key promotional strategies and initiatives, leveraging focused market insights, contributing to strong YOY growth of 19% [2019] & 30% [2020], building the fastest growing Janssen brand, on track for 2021 domestic blockbuster status (>$1B in sales)• Developed new attitudinal and behavior-based customer segmentation in collaboration with cross functional stakeholders, forming the foundation for all Sales & Marketing plans and KPIs• Drove updated product positioning and HCP messaging leading to >71% aided top message recall• Partnered with medical teams to develop integrated evidence generation plan to prioritize clinical trial and real world evidence generation for commercialization• Led cross-functional team to develop multichannel strategic plan to improve patient persistency; resulting in a 1.6% improvement in the first 6 months• Collaborated with medical teams to develop evidence generation plan and clinical trial direction• Competitive differentiation lead; managing competitive simulations, messaging, and sales training• Developed web-based interactive virtual case study programs, in partnership with a national KOL; leading to a 40% increase in prescriptions from program participants• Developed market shaping white papers to drive adoption of objective risk assessment in partnership with national KOLs to increase Standard of Care• Led both virtual and in-person advisory boards with national KOLs, nurses, and patient advisors to inform market development strategies to improve Standard of Care

Overall management and execution of both HCP and patient promotion. Led market shaping strategies to both drive diagnosis of rare disease and elevate the standard of care within the oncology/dermatology space for MF-CTCL. Managed relationship with Key Opinion Leaders, Patient Advocacy Groups, and other external stakeholders to drive awareness and branded growth in a generic marketplace.• Led market shaping initiatives including developing clinically validated MF-CTCL patient reported outcomes tool and disease education campaign in partnership with medical colleagues • Developed and launched updated VALCHLOR HCP and patient positioning and digital campaigns; resulting in 30% improvement in unaided awareness• Managed end-to-end live speaker bureau training events and execution of >175 key opinion leader speaker events for both VALCHLOR and unbranded speaker programs and webcasts series

Interim Dermatomyositis and Polymyositis Lead and Lead Portfolio Marketing Manager for Rheumatology Indication. Managing overall KOL relationship and Advisory board planning to drive strategic and promotional insights. Overall management of medical conference and in-person marketing events to drive 20% growth in brand awareness through annual ATU studies.• Developed and managed KOL engagement initiatives including HCP speaker bureau and advisory boards with national and regional thought leaders to shape product positioning and launch messaging• Launched and managed Rheumatology franchise patient support and adherence programs, driving a 20% increase in treatment initiation rates and improving average patient adherence by ~2 months

Launched Acthar into Rheumatology therapeutic area.Managed training, contracting, and overall management of entire Physician Speaker Bureau since inception.Developed and managed Acthar promotional material for patient and HCP audiences.Led National and regional conference management and message developmentDeveloped and managed budget for multiple rheumatology indications in excess of $5.5M.Trained and executed all new hire sales training of national rheumatology sales force.

Management of XDx's communication program; relaying specific messaging and branding to both patients and physicians. Management of AlloMap's social networks and presence in the online community.• Developed and transitioned commercial salesforce to digital collateral, increasing HCP engagement• Managed in-person marketing events and professional conference/congress plans

Revise and develop standard operating procedures regarding paid to patient reimbursement collection, payer appeals, and patient case management escalation to increase revenue and streamline private health insurance and government payer appeals process. Focused on identifying and resolving payer reimbursement case management process inefficiencies and improve system interfaces to increase Hub team efficiencies nearly 30%.Produce quarterly financial analysis of reimbursement backlog in excess of $600,000, achieving over $170,000 in reimbursements collections.Assist with management of billing vendor and database transition while identifying and resolving issues with web interfaces; increasing team efficiency nearly 30%.

• Managed the entire research lab and oversaw 6 research assistants in 3 different clinical optometric studies• Collected and organized research data of over 24 human subjects and analyzed distinct trends• Explained and guided research subjects through over 12 visual and Vernier acuity tests weekly• Assisted principal investigator with subject screenings, including scribing & trial frame preparation • Scheduled subject appointment times, including coordinating transportation accommodations for subjects

• Participated in a 3 month rotation with over 7 different Criminalist in 5 different Forensic Evidence Units• Conducted sample evidence examination in fields of Blood Alcohol, Latent, Firearms, and Forensic Biology• Adopted and performed evidence gathering and field techniques in several mock criminal case scenarios

• Administered various visual acuity tests, vision field tests, and eye exams to patients before doctor screening• Prepared patients for eye screening by administering fluorescence and local anesthetic before exams• Helped principal investigator scribe screening data for an average of 16 eye exam screenings weekly• Acted as a translator between the Ophthalmologist, his clinical technicians and the various foreign patients• Organized and sorted over 1000 reports and patient result sheets, increasing efficacy of reporting